Trial · NCT06325956
PCOS Immune Function Predicts Metformin Efficacy
NCT06325956, Not applicable, Unknown, Shanghai 10th People's Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. PCOS Immune Function Predicts Metformin Efficacy. Trials, record NCT06325956. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06325956
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- PCOS Immune Function Predicts Metformin Efficacy
- NCT number
- NCT06325956
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Shanghai 10th People's Hospital
- Conditions
- Polycystic Ovary Syndrome, Metformin, Immune Function
- Interventions
- Metformin
- First posted
- 2024-03-22
- Last updated
- 2024-03-22
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The number of cell groups expressing different markers were counted by the fluorescence detection system on flow cytometry. | Samples to be collected once per participant within 7 days of enrollment. | Flow cytometry was used to detect the antigenic antibody reaction between the surface differentiation antigen of lymphocyte membrane and the fluorescently labeled antibody in human peripheral blood, and the unlabeled cells were dissolved. |
| Primary | The percentage of cell groups expressing different markers were counted by the fluorescence detection system on flow cytometry. | Samples to be collected once per participant within 7 days of enrollment. | Flow cytometry was used to detect the antigenic antibody reaction between the surface differentiation antigen of lymphocyte membrane and the fluorescently labeled antibody in human peripheral blood, and the unlabeled cells were dissolved. |
| Secondary | Homeostasis model assessment of insulin resistance | Within 7 days of enrollment. | insulin resistance index |
| Secondary | body mass index | Within 7 days of enrollment. | body mass index (kg/m2) |
| Secondary | menstrual frequency | Within 7 days of enrollment. | number of menstruation in a year |
| Secondary | fasting glucose | Within 7 days of enrollment. | fasting glucose (mmol/L) |
| Secondary | fasting insulin | Within 7 days of enrollment. | fasting insulin (mmol/L) |
| Secondary | Total cholesterol | Within 7 days of enrollment. | Total cholesterol (mmol/L) |
| Secondary | Triglycerides | Within 7 days of enrollment. | Triglycerides (mmol/L) |
| Secondary | HDL-c | Within 7 days of enrollment. | HDL-c (mmol/L) |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06325956
GET https://conductscience.org/api/trials/v1/NCT06325956/registered